16 May 2026
: Case report
Long-Term Response to Pembrolizumab in Metastatic Metaplastic Breast Carcinoma: A Case Report
Unusual clinical course, Unusual or unexpected effect of treatment
Yuki Oshima ABCDEF 1, Takamasa Suzuki D 1, Yumi Fukaya D 1, Keiko Hosoya D 1, Yuko Tanaka D 1, Makoto Wakahara ABCDEF 1*, Yoshihisa Umekita CD 2, Yugo Tanaka ABCDEF 1DOI: 10.12659/AJCR.952330
Am J Case Rep 2026; 27:e952330
Figure 4 Immunohistochemical findings. The initial surgical specimen was PD-L1-positive with a combined positive score of 83.2% (using PD-L1 IHC 22C3 pharmDx) (×200).






